Thrombin generation in newly diagnosed multiple myeloma during the first three cycles of treatment: An observational cohort study.

The only factor associated with a reduction in early thrombotic risk was prophylaxis with LMWH. The issue of how to identify patients requiring prophylactic anticoagulation remains unresolved.